GlobeNewswire, Inc.

REYKJAVIK, Iceland, May 06, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ US: ALVO, ICELAND: ALVO, STOCKHOLM: ALVO SDB) Financial Highlights A supplemental long‑form earnings release providing additional operational details and business update for Q1...

GlobeNewswire, Inc.

Declares Dividend of $0.35 per Share for Q1 2026, Marking 133% Increase Year-Over-Year and 27th Consecutive Quarterly Dividend Expects Significantly Higher Q2 2026 Dividend High Specification Scrubber-Fitted Capesize Vessel Expected to Deliver in...

GlobeNewswire, Inc.

EL SEGUNDO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ: BYND), otherwise known as Beyond The Plant Protein CompanyTM (the “Company” or “Beyond Meat”), today reported financial results for its first quarter ended March 28,...

GlobeNewswire, Inc.

Exceeds high end of first quarter guidance on revenue and profitability Raises 2026 revenue guidance to 15% year over year growth Highlights Revenue grew 20% year over year to $1.85 billion Product revenue grew 41% year over year to $645 million...

GlobeNewswire, Inc.

Generated first quarter XDEMVY® net product sales of more than $145 million, an increase of more than 85% year-over-year Reaffirmed full-year 2026 guidance of $670-700 million of XDEMVY net product sales and peak sales potential exceeding $2...

GlobeNewswire, Inc.

PiNACLE pivotal clinical trial evaluating ronde-cel in patients with LBCL in third- or later-line setting on track to report additional data in second half of 2026, with pivotal data expected mid-2027 and BLA submission expected to follow in 2027...